Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07760948
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes AssociationNot Yet RecruitingPhase 2
NCT07760948Not Yet Recruiting
Phase 2
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes Associa...
NCT07759739
Er:YAG Laser Versus Conventional Cavity Preparation in Children With Molar-Incisor HypomineralizationEge UniversityActive Not RecruitingNot Applicable
NCT07759739Active Not Recruiting
Not Applicable
Er:YAG Laser Versus Conventional Cavity Preparation in Children With Molar-Incis...Ege University
NCT07760779
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and Brief MindfulnessNational Institute on Aging (NIA)Not Yet RecruitingNot Applicable
NCT07760779Not Yet Recruiting
Not Applicable
Addressing Nocturia in Older Women Utilizing Behavioral Sleep Intervention and B...National Institute on Agi...
NCT07759973
Neurocomputational Dynamics of CooperationEmory UniversityNot Yet RecruitingNot Applicable
NCT07759973Not Yet Recruiting
Not Applicable
Neurocomputational Dynamics of CooperationEmory University
NCT07759297
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac SurgeryShusheng LiCompleted
NCT07759297Completed
—
Intraoperative Dexmedetomidine Use and Postoperative Delirium After Cardiac Surg...Shusheng Li
NCT07761377
Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis on Chest CTTaichung Veterans General HospitalRecruiting
NCT07761377Recruiting
—
Retrospective Validation of AccuPulmo CT Portal for Detecting Pulmonary Fibrosis...Taichung Veterans General...
NCT07759427
Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular TachycardiaUniversity Hospitals Coventry and Warwickshire NHS TrustRecruitingNot Applicable
NCT07759427Recruiting
Not Applicable
Using Non-Invasive Mapping To Eliminate Structural Heart Disease Ventricular Tac...University Hospitals Cove...
NCT07761026
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures the Real-world Experiences of People Living With Autoimmune Neurology Conditions. Launching in Myasthenia Gravis (MG), we Plan to Evaluate Expansion to Other Conditions Across Autoimmune Neurology.Alira HealthRecruiting
NCT07761026Recruiting
—
The AXIS Registry is a 10-year Longitudinal Research Initiative That Captures th...Alira Health
NCT07759115
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility StudyNational Institute of Nursing Research (NINR)Not Yet RecruitingNot Applicable
NCT07759115Not Yet Recruiting
Not Applicable
Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feas...National Institute of Nur...
NCT07761130
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)Health Research Board, IrelandCompletedNot Applicable
NCT07761130Completed
Not Applicable
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke...Health Research Board, Ir...
NCT07759362
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT)Endo USA Inc., a Keenova Therapeutics CompanyNot Yet RecruitingPhase 3
NCT07759362Not Yet Recruiting
Phase 3
Study to Assess KN3835 in the Treatment of Flexible/Semi-Flexible Hammertoe (HMT...Endo USA Inc., a Keenova...
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07761351
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted BronchoscopyIntuitive SurgicalNot Yet RecruitingPhase 4
NCT07761351Not Yet Recruiting
Phase 4
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-...Intuitive Surgical
NCT07760714
A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4/6 Inhibition in HR+, HER2-negative Metastatic Breast Cancer PatientsNovartis PharmaceuticalsCompleted
NCT07760714Completed
—
A Real-World Study of Treatment Patterns, Tolerability and Effectiveness of CDK4...Novartis Pharmaceuticals
NCT07759999
Clinical Evaluation of a Treatment Planning Software and Oncology Information System for Proton TherapyUniversity of Wisconsin, MadisonRecruitingNot Applicable
NCT07759999Recruiting
Not Applicable
Clinical Evaluation of a Treatment Planning Software and Oncology Information Sy...University of Wisconsin,...
NCT07760324
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Disease Research in ZambiaSuspended
NCT07760324Suspended
—
CD4 Cell Count at Antiretroviral Therapy Initiation or Re- InitiationCentre for Infectious Dis...
NCT07759661
Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination TherapiesIRCCS San RaffaeleNot Yet Recruiting
NCT07759661Not Yet Recruiting
—
Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Perso...IRCCS San Raffaele
NCT07759895
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Symptoms in SchizophreniaAmit LotanNot Yet RecruitingPhase 2
NCT07759895Not Yet Recruiting
Phase 2
Combination Therapy of Deferiprone and N-Acetylcysteine for Treating Negative Sy...Amit Lotan
NCT07761728
The FLARE (Flurpiridaz vs. Rubidium Evaluation) TrialUniversity of California, Los AngelesRecruiting
NCT07761728Recruiting
—
The FLARE (Flurpiridaz vs. Rubidium Evaluation) TrialUniversity of California,...
NCT07761598
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs instituteNot Yet RecruitingNot Applicable
NCT07761598Not Yet Recruiting
Not Applicable
The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY.Jacobs institute
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Completed3 (15%)
Active, not recruiting1 (5%)
Suspended1 (5%)
not_applicable9 (45%)
Not Specified7 (35%)
Phase 22 (10%)
Phase 31 (5%)
Phase 41 (5%)